Disclosed is the use of a therapeutically effective amount of an extract or latex isolated from Croton spp. or Calophyllum spp. which is effective to treat alternating constipation-predominant/diarrhea-predominant irritable bowel syndrome (a-IBS) in the manufacture of a medicament for the treatment of a-IBS.